SMi's 10th annual conference on imaging for drug development will provide delegates discussions into current and future legislation and its impact on imaging. The use of imaging in clinical trials will also be examined and debated together with the use of novel biomarkers.

Research suggests that personalised healthcare is the way forward, this event will be considering the current landscape of personalised imaging within the field of oncology. Attendees will be give an excellent platform in 2014 for learning about the use of imaging in clinical trials, giving delegates access to the latest information and case studies across the industry.

This 2 day event will be an excellent opportunity for professionals working in imaging to talk to renowned speakers. There will be a diverse selection of speakers, representing all areas of the field. From US to UK, attendees will gain a broad analysis of ideas, challenges and solutions.

Benefits of Attending
•     Consider the challenges and successes in imaging
•     Examine use of imaging in early phase clinical trials
•     Understand and discuss the use of imaging clinically
•     Gain a strategic overview of imaging in practice
•     Scrutinise the regulatory developments, especially the Clinical Trials Directive

**Book by 29th November 2013 and save £300**
**Book by 1st January 2014 and save £100**

For full programme, brochure and more information please visit our website